(Q40723790)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

title

Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Corrado Girmenia

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

A Micozzi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

M Venditti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

G Gentile

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

G Meloni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

P Martino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Microbiology & Infectious Diseases

30 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

1-8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8385015%20AND%20SRC:MED&resulttype=core&format=json

Ceftriaxone-induced cholelithiasis

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Piperacillin plus amikacin vs. piperacillin plus amikacin plus teicoplanin for empirical treatment of febrile episodes in neutropenic patients receiving quinolone prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Comparative in vitro activities of new fluorinated quinolones and other antibiotics against coagulase-negative Staphylococcus blood isolates from neutropenic patients, and relationship between susceptibility and slime production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Empiric antibacterial therapy in granulocytopenia induced by cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Comparative in vitro activities of piperacillin-tazobactam and ticarcillin-clavulanate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01997049

Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).

21 January 2018

1 reference

12 December 2020

Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients

1 reference

12 December 2020

Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignancies.

1 reference

12 December 2020

Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Canc

1 reference

12 December 2020

Piperacillin/tazobactam (YTR 830) combination. Comparative antimicrobial activity against 5889 recent aerobic clinical isolates and 60 Bacteroides fragilis group strains

1 reference

12 December 2020

Streptococcal sepsis in bone marrow transplant patients

1 reference

12 December 2020

Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adult

1 reference

12 December 2020

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

1 reference

12 December 2020

Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer

1 reference

12 December 2020

Evolution of antibiotic therapy for infection in neutropenic patients: studies at M. D. Anderson Hospital

1 reference

12 December 2020

Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanate and sulbactam combined with extended-spectrum penicillins against ticarcillin-resistant Enterobacteriaceae and pseudomonads

1 reference

12 December 2020

Adult respiratory distress syndrome in patients with severe neutropenia

1 reference

12 December 2020

Activity of ticarcillin/clavulanate and piperacillin/tazobactam (YTR 830; CL-298,741) against clinical isolates and against mutants derepressed for class I beta-lactamase.

1 reference

12 December 2020